С.Мөнхбат
Loading...
Товч нэр
С.Мөнхбат
Бүтэн нэр
Сүхээ Мөнхбат
Латин нэр
Sukhee Munkhbat
Албан тушаал
Тэнхимийн эрхлэгч
Эрдмийн цол
Дэд профессор
Боловсролын зэрэг
Доктор (Ph.D)
ORCID
Scopus Author ID
2 results
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Potentially Inappropriate Medications in Hospitalized Elderly Patients with Kidney Disease(Mongolian National University of Medical Sciences, 2019-09-25); ;Ganbold, Dashdulam ;Olonbayar, Otgonjargal; Bayarkhangai, BuuveeObjective: Our purpose was to use the Beers criteria to determine potentially inappropriate medications in people 65 years of age and older who were hospitalized in the Nephrology and Endocrinology Department of The Second General Hospital in Ulaanbaatar, Mongolia from October to December in 2017. Methods: A total of 75 patients’ medical records were selected who were aged ≥ 65 and diagnosed with kidney diseases. The patient’s age, sex, serum creatinine, the number of potentially inappropriate medications prescribed were determined. Descriptive statistics, frequency analysis, and t-tests were used for normally distributed variables. The Mann-Whitney U test was used for variables with a non-normal distribution. Results: Most patients for whom data were creatine clearance data were available (36/41, 87%) were prescribed at least one potentially inappropriate medication, and the number prescribed of potentially inappropriate medications was moderately correlated with length of hospital stay (r= .326, p < .05). The frequency of potentially inappropriate medications prescribed in patients with CrCL <60 ml/min was significantly higher than in patients with CrCL level 60 – 90 ml/min (29/31 vs. 7/10, X2 (1) = 50.45, p < .001). A total of 195 potentially inappropriate medications were prescribed to 75 elderly patients diagnosed with renal disease, and these included antibiotics, anticonvulsants, proton pump inhibitors, and calcium channel blockers. Conclusion: Potentially inappropriate medications were frequently prescribed to hospitalized geriatric patients with kidney disease. Health care professionals in Mongolia need to collaborate to optimize pharmacotherapy based on renal function to avoid the complications of potentially inappropriate medications for geriatric patients with kidney disease. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antibiotic and antiviral prescribing patterns among hospitalised patients with COVID-19 pneumonia in Mongolia: a real-world descriptive retrospective studyBACKGROUND: During the COVID-19 pandemic, Mongolia, like many low- and middle-income countries, faced major healthcare delivery challenges due to limited system readiness, resource constraints, geopolitical vulnerabilities, and prolonged border closures. These factors caused shortages of laboratory reagents and globally recommended therapeutics, including remdesivir and tocilizumab, prompting clinicians to use alternative antivirals and empirical broad-spectrum antibiotics. OBJECTIVE: To evaluate and compare real-world prescribing patterns of antibiotics and antivirals among hospitalised patients with COVID-19 pneumonia at Mongolia's two largest tertiary referral facilities: Mongolia-Japan Hospital (MJH) and the National Center for Communicable Diseases (NCCD). METHODS: This retrospective cross-sectional study analysed anonymised medical charts and electronic health records of 1012 adults with PCR-confirmed COVID-19 pneumonia hospitalised between 18 April and 31 December 2021. Demographics, comorbidities, laboratory markers, and pharmacological treatments were systematically extracted and compared between the two institutions. RESULTS: Antibiotics were prescribed to 87.6% (887/1012) of patients. Cephalosporins were the most frequently prescribed class (89.3%, 904/1012), followed by macrolides (36.5%, 369/1012) and fluoroquinolones (33.5%, 339/1012). Multi-drug empiricism was common, with beta-lactam, macrolide, and quinolone combinations accounting for 70.8% (68/96) of triple-antibiotic regimens. Antivirals were administered to over 90% of patients, predominantly umifenovir (52.2%) and favipiravir, supported by domestic stockpiles and Eurasian trade networks. Remdesivir was rarely used, while tocilizumab was administered to only 2 patients (0.2%). Hypertension and diabetes were significantly more frequent in the MJH cohort, reflecting differences in catchment populations and screening practices. CONCLUSION: The high rate of empirical broad-spectrum antibiotic use and reliance on alternative antivirals reflect pragmatic clinical adaptations to diagnostic reagent shortages and therapeutic supply inequities. These findings highlight the need for national antimicrobial stewardship programmes, strengthened microbiological diagnostic capacity, and digitised clinical registries to improve healthcare system resilience in resource-constrained settings.
